A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Clinical trial NCT01896102 · COMPLETED
Trial details
- NCT number
- NCT01896102
- Sponsor
- Genetix Biotherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-21
- Primary completion
- 2021-03-26
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.